Skip to main content
OpenTrials
Completed

NCT Number: NCT00411320

Determinants of Corticosteroid Insensitivity in Smokers With Asthma

Smokers with asthma display a relative insensitivity to inhaled and oral corticosteroids. The causes of this phenomenon are currently unknown. The investigators will perform a number of blood & breathing tests to try to discover the cause/s behind this phenomenon with the aim of producing leads for further investigation and possible new treatments for smokers with asthma.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Asthma Research Unit, Glasgow University

Glasgow, Scotland, G12 0YN, United Kingdom

About this study

Smokers with asthma display a relative insensitivity to inhaled and oral corticosteroids. The causes of this phenomenon are currently unknown. However research into steroid resistance in severe asthma and the smoking related condition chronic obstructive pulmonary disease (COPD) points to a number of possible causes. We will characterise a group of smokers with asthma and perform a number of investigations and compare the results to ex-smokers and never smokers with asthma with the aim of establishing which previously published steroid resistance phenomena are related to the steroid resistance displayed by smokers with asthma. Results produced from this trial will provide hypothesis generating information leading to future pharmaceutical trials.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Asthma (defined by either reversibility to bronchodilator or methacholine testing)
  • Asthma duration of 6 months or greater
  • Stable asthma
  • Age 18-60
  • Treatment with inhaled corticosteroids
  • Smoking history consistent with group
  • smokers with asthma: > or = 5 pack years and currently smoking more than 5 cigarettes per day
  • ex-smokers: smoking ceased > or = two years prior to recruitment, minimum 5 pack year history
  • non-smokers: no smoking history

Exclusion criteria

  • Presence of medical condition likely to be exacerbated by treatment with oral corticosteroids
  • Treatment with > 2000 mcg beclomethasone (or equivalent) per day
  • Subject requires oral corticosteroids to maintain asthma control
  • Subject requires oral theophylline to maintain asthma control
  • Recent treatment with oral corticosteroids
  • Pregnancy or subject planning to become pregnant

Treatment and study plan

oral steroid-dexamethasone

Drug

2 week steroid trial

Primary outcomes

  1. bronchodilator response to oral corticosteroid trial in smokers with asthma vs non smokers and ex-smokers with asthma

    Time frame: 2 weeks

Sponsors and collaborators

Lead sponsor

University of Glasgow

Other

Collaborators

  • Chief Scientist Office of the Scottish Government

Registry information

Important dates

Study start
2007
Primary completion
2010
Study completion
2010
First posted
Dec 14, 2006
Registry last updated
Aug 4, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.